Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Prime Medicine, Inc. PRME |
Newpath Partners, L.P. | 6,105,679 4.700% |
800,000 (+15.08%) |
Filing History |
| 2024-11-22 5:32 pm Purchase |
2024-11-12 | 13D | Prime Medicine, Inc. PRME |
ARCH Venture Fund XII, L.P. | 15,511,736 11.800% |
39,062 (+0.25%) |
Filing History |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Prime Medicine, Inc. PRME |
FMR CORP | 7,726,649 6.437% |
-1,361,501 (-14.98%) |
Filing History |
| 2024-10-04 4:20 pm Purchase |
2023-09-30 | 13G | Prime Medicine, Inc. PRME |
BRISTOL MYERS SQUIBB CO BMY |
11,006,163 8.400% |
11,006,163 (New Position) |
Filing History |
| 2024-02-29 4:15 pm Purchase |
2024-02-20 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 15,062,498 12.200% |
3,200,000 (+26.98%) |
Filing History |
| 2024-02-22 9:31 pm Purchase |
2024-02-15 | 13D | Prime Medicine, Inc. PRME |
ARCH Venture Fund XII, L.P. | 15,472,674 12.900% |
15,472,674 (New Position) |
Filing History |
| 2024-02-09 4:09 pm Sale |
2023-12-31 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 11,862,498 12.200% |
-1,422,190 (-10.71%) |
Filing History |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Prime Medicine, Inc. PRME |
FMR CORP | 9,088,150 9.338% |
625,104 (+7.39%) |
Filing History |
| 2023-02-13 4:08 pm Purchase |
2022-12-31 | 13G | Prime Medicine, Inc. PRME |
ARCH Venture Fund X L.P. | 12,272,674 12.600% |
12,272,674 (New Position) |
Filing History |
| 2023-02-10 4:05 pm Purchase |
2022-12-31 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 13,284,688 13.700% |
13,284,688 (New Position) |
Filing History |
| 2023-02-09 08:14 am Purchase |
2023-02-09 | 13G | Prime Medicine, Inc. PRME |
FMR CORP | 8,463,046 8.706% |
100 (+0.00%) |
Filing History |
| 2023-02-07 4:46 pm Purchase |
2022-12-31 | 13G | Prime Medicine, Inc. PRME |
Newpath Partners, L.P. | 5,305,679 5.500% |
5,305,679 (New Position) |
Filing History |
| 2022-10-26 10:20 am Purchase |
2022-10-26 | 13G | Prime Medicine, Inc. PRME |
FMR CORP | 8,462,946 8.840% |
8,462,946 (New Position) |
Filing History |